Ruxolitinib-induced spleen size reduction predicts superior outcome after allogeneic stem cell transplantation in primary and post-PV/ET myelofibrosis - a study of the Cooperative German Transplant Study Group (KTS)
Bone Marrow Transplantation（2016）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要